Neuroendocrine Carcinoma of the Cervix Overview

Save information for later
Sign Up

Learn About Neuroendocrine Carcinoma of the Cervix

Who are the top Neuroendocrine Carcinoma of the Cervix Local Doctors?
Anuja Jhingran
Elite in Neuroendocrine Carcinoma of the Cervix
Radiation Oncology
Elite in Neuroendocrine Carcinoma of the Cervix
Radiation Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English

Anuja Jhingran is a Radiation Oncologist in Houston, Texas. Dr. Jhingran is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. Her top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, and Vaginal Cancer.

Pedro T. Ramirez
Distinguished in Neuroendocrine Carcinoma of the Cervix
Gynecologic Oncology | Oncology
Distinguished in Neuroendocrine Carcinoma of the Cervix
Gynecologic Oncology | Oncology

Tmh Physician Associates PLLC

6550 Fannin St, Suite 901, 
Houston, TX 
Languages Spoken:
English
Accepting New Patients

Pedro Ramirez is a Gynecologic Oncologist and an Oncologist in Houston, Texas. Dr. Ramirez is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. His top areas of expertise are Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Hysterectomy, and Endoscopy. Dr. Ramirez is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Jyoti S. Mayadev
Distinguished in Neuroendocrine Carcinoma of the Cervix
Radiation Oncology
Distinguished in Neuroendocrine Carcinoma of the Cervix
Radiation Oncology

Regents Of The University Of California

3855 Health Sciences Dr, 
La Jolla, CA 
Languages Spoken:
English

Jyoti Mayadev is a Radiation Oncologist in La Jolla, California. Dr. Mayadev is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Carcinoma of the Cervix. Her top areas of expertise are Cervical Cancer, Vulvar Cancer, Neuroendocrine Carcinoma of the Cervix, Endometrial Cancer, and Lymphadenectomy.

What are the latest Neuroendocrine Carcinoma of the Cervix Clinical Trials?
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance

Summary: The primary objective of this study, sponsored by Travera Inc. in Massachusetts, is to validate whether the mass response biomarker has potential to predict response of patients to specific therapies or therapeutic combinations using isolated tumor cells from various specimen formats including malignant fluids such as pleural effusions and ascites, core needle biopsies, fine needle aspirates, or r...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix

Summary: This study collects information and data on patients with neuroendocrine cervical cancer. Information from this study may be used to better understand the correlation between clinical data, such as patient characteristics, treatment, and disease outcomes, and overall patient outcomes.

Who are the sources who wrote this article ?

Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center